Related Experiment Video
Updated: Oct 9, 2026
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Accumulation of the 1-methyl-4-phenylpyridinium ion in suncus (Suncus murinus) brain: implication for
T Mushiroda1, N Ariyoshi, T Yokoi
1Laboratory of Drug Metabolism, Division of Pharmacobio-dynamics, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Hokkaido 060-0812, Japan.
Abstract:
The metabolism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was examined in an effort to evaluate the role of flavin-containing monooxygenase (FMO) expressed in the brain of suncus (Suncus murinus) and rats. MPTP was metabolized to generate both 1-methyl-4-phenylpyridinium ion (MPP(+)) and MPTP N-oxide by brain homogenates from rats. Although the level of MPP(+)-producing activity was similar in suncus and rats, a remarkable difference was found between the animal species in MPTP N-oxygenase activity, which was not detectable in brain homogenates from suncus. The concentrations of MPP(+) in suncus brain after a single ip administration of MPTP were markedly higher than that in rats, probably because of the lack of FMO activity in the suncus brain. The MPTP N-oxygenase activity of microvessel homogenates of rat brain was 21-fold greater than that of whole brain homogenates. These results suggest that FMO(s) plays a significant role in the detoxification of MPTP in cerebral endothelial cells.
Insights
Flavin-containing monooxygenase (FMO) in the brain is crucial for detoxifying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Suncus brains, lacking FMO activity, showed higher MPP+ concentrations after MPTP exposure compared to rats.
Area of Science:
- Neuroscience
- Biochemistry
- Pharmacology
Background:
- 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin that causes Parkinsonism.
- Flavin-containing monooxygenases (FMOs) are enzymes involved in xenobiotic metabolism.
- The role of brain FMOs in MPTP metabolism and neurotoxicity is not fully understood.
Purpose of the Study:
- To investigate the role of brain flavin-containing monooxygenase (FMO) in the metabolism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
- To compare MPTP metabolism and neurotoxicity in suncus (Suncus murinus) and rats, focusing on FMO activity.
Main Methods:
- Comparative analysis of MPTP metabolism in brain homogenates from suncus and rats.
- Measurement of 1-methyl-4-phenylpyridinium ion (MPP(+)) and MPTP N-oxide production.
- Assessment of MPTP N-oxygenase activity in whole brain and microvessel homogenates.
Main Results:
- Rat brain homogenates metabolized MPTP to MPP(+) and MPTP N-oxide.
- MPTP N-oxygenase activity was detected in rat brain but not in suncus brain.
- Suncus brains exhibited significantly higher MPP(+) concentrations after MPTP administration compared to rats.
- Rat brain microvessel homogenates showed substantially higher MPTP N-oxygenase activity than whole brain homogenates.
Conclusions:
- Flavin-containing monooxygenases (FMOs) in the brain, particularly in cerebral endothelial cells, play a significant role in MPTP detoxification.
- The absence of FMO activity in suncus brain contributes to higher MPP(+) accumulation and potential neurotoxicity.
- FMOs represent a critical defense mechanism against MPTP-induced neurotoxicity in the brain.
